These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21798777

  • 1. QM and QM/MD simulations of the Vinca alkaloids docked to tubulin.
    Kelly EB, Tuszynski JA, Klobukowski M.
    J Mol Graph Model; 2011 Sep; 30():54-66. PubMed ID: 21798777
    [Abstract] [Full Text] [Related]

  • 2. Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin.
    Chi S, Xie W, Zhang J, Xu S.
    J Biomol Struct Dyn; 2015 Sep; 33(10):2234-54. PubMed ID: 25588192
    [Abstract] [Full Text] [Related]

  • 3. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S, Fu Y, Zu Y, Rebacz B, Konkimalla B, Plinkert PK, Krämer A, Gertsch J, Efferth T.
    Biochem Pharmacol; 2011 Mar 15; 81(6):723-35. PubMed ID: 21219884
    [Abstract] [Full Text] [Related]

  • 4. [Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine].
    Tsvetkov FO, Kulikova AA, Devred F, Zerniĭ EIu, Lafitte D, Makarov AA.
    Mol Biol (Mosk); 2011 Mar 15; 45(4):697-702. PubMed ID: 21954603
    [Abstract] [Full Text] [Related]

  • 5. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S, Vulevic B, Correia JJ.
    Biochemistry; 1996 May 28; 35(21):6806-14. PubMed ID: 8639632
    [Abstract] [Full Text] [Related]

  • 6. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S, Frankfurter A, Correia JJ.
    Cell Motil Cytoskeleton; 1998 May 28; 39(2):107-21. PubMed ID: 9484953
    [Abstract] [Full Text] [Related]

  • 7. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids.
    Coderch C, Morreale A, Gago F.
    Anticancer Agents Med Chem; 2012 Mar 28; 12(3):219-25. PubMed ID: 22044006
    [Abstract] [Full Text] [Related]

  • 8. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA, Tsvetkov PO, Villard C, Esquieu D, Pourroy B, Fahy J, Braguer D, Peyrot V, Lafitte D.
    Biochemistry; 2007 Dec 25; 46(51):14899-906. PubMed ID: 18052208
    [Abstract] [Full Text] [Related]

  • 9. The binding of vinca domain agents to tubulin: structural and biochemical studies.
    Cormier A, Knossow M, Wang C, Gigant B.
    Methods Cell Biol; 2010 Dec 25; 95():373-90. PubMed ID: 20466145
    [Abstract] [Full Text] [Related]

  • 10. The thermodynamics of vinca alkaloid-induced tubulin spirals formation.
    Lobert S, Ingram JW, Correia JJ.
    Biophys Chem; 2007 Mar 25; 126(1-3):50-8. PubMed ID: 16757093
    [Abstract] [Full Text] [Related]

  • 11. Novel aspects of natural and modified vinca alkaloids.
    Duflos A, Kruczynski A, Barret JM.
    Curr Med Chem Anticancer Agents; 2002 Jan 25; 2(1):55-70. PubMed ID: 12678751
    [Abstract] [Full Text] [Related]

  • 12. Elaboration of simplified vinca alkaloids and phomopsin hybrids.
    Ngo QA, Roussi F, Thoret S, Guéritte F.
    Chem Biol Drug Des; 2010 Mar 25; 75(3):284-94. PubMed ID: 20659111
    [Abstract] [Full Text] [Related]

  • 13. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules.
    Himes RH.
    Pharmacol Ther; 1991 Mar 25; 51(2):257-67. PubMed ID: 1784631
    [Abstract] [Full Text] [Related]

  • 14.
    Chen RJ, Menezes RG.
    ; 2024 01 25. PubMed ID: 32491774
    [Abstract] [Full Text] [Related]

  • 15. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C, Brichese L, Barret JM, Tollon Y, Kruczynski A, Hill BT, Wright M.
    Anticancer Drugs; 1999 Jul 25; 10(6):537-43. PubMed ID: 10885901
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of hybrid molecules targeting the vinca domain of tubulin.
    Gherbovet O, Sánchez-Murcia PA, García Alvarez MC, Bignon J, Thoret S, Gago F, Roussi F.
    Org Biomol Chem; 2015 Mar 14; 13(10):3144-54. PubMed ID: 25634805
    [Abstract] [Full Text] [Related]

  • 17. A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity.
    Lobert S, Ingram JW, Hill BT, Correia JJ.
    Mol Pharmacol; 1998 May 14; 53(5):908-15. PubMed ID: 9584218
    [Abstract] [Full Text] [Related]

  • 18. Structural plasticity of tubulin assembly probed by vinca-domain ligands.
    Ranaivoson FM, Gigant B, Berritt S, Joullié M, Knossow M.
    Acta Crystallogr D Biol Crystallogr; 2012 Aug 14; 68(Pt 8):927-34. PubMed ID: 22868758
    [Abstract] [Full Text] [Related]

  • 19. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT.
    Biochem Pharmacol; 1998 Mar 01; 55(5):635-48. PubMed ID: 9515574
    [Abstract] [Full Text] [Related]

  • 20. Energetics of vinca alkaloid interactions with tubulin.
    Lobert S, Correia JJ.
    Methods Enzymol; 2000 Mar 01; 323():77-103. PubMed ID: 10944748
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.